128 related articles for article (PubMed ID: 21051231)
1. Synthesis of D- and L-tyrosine-chlorambucil analogs active against breast cancer cell lines.
Descôteaux C; Leblanc V; Brasseur K; Gupta A; Asselin E; Bérubé G
Bioorg Med Chem Lett; 2010 Dec; 20(24):7388-92. PubMed ID: 21051231
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of estradiol-chlorambucil hybrids as anticancer agents.
Gupta A; Saha P; Descôteaux C; Leblanc V; Asselin E; Bérubé G
Bioorg Med Chem Lett; 2010 Mar; 20(5):1614-8. PubMed ID: 20137939
[TBL] [Abstract][Full Text] [Related]
3. SAR study of tyrosine-chlorambucil hybrid regioisomers; synthesis and biological evaluation against breast cancer cell lines.
Descôteaux C; Brasseur K; Leblanc V; Parent S; Asselin E; Bérubé G
Amino Acids; 2012 Aug; 43(2):923-35. PubMed ID: 22102055
[TBL] [Abstract][Full Text] [Related]
4. Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines.
Descôteaux C; Brasseur K; Leblanc V; Parent S; Asselin E; Bérubé G
Steroids; 2012 Apr; 77(5):403-12. PubMed ID: 22227028
[TBL] [Abstract][Full Text] [Related]
5. To determine the cytotoxicity of chlorambucil and one of its nitro-derivatives, conjugated to prasterone and pregnenolone, towards eight human cancer cell-lines.
Shervington LA; Smith N; Norman E; Ward T; Phillips R; Shervington A
Eur J Med Chem; 2009 Jul; 44(7):2944-51. PubMed ID: 19121874
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity studies of novel amidine analogues of chlorambucil: correlation of cytotoxic activity with DNA-binding affinity and topoisomerase II inhibition.
Bielawska A; Bielawski K; Wołczyński S; Anchim T
Arch Pharm (Weinheim); 2003 Aug; 336(6-7):293-9. PubMed ID: 12953217
[TBL] [Abstract][Full Text] [Related]
8. [N-ethyl- and [N,N'-diethyl-1,2-bis(2,6-difluoro-3-hydroxyphenyl)-ethylenediamine]dichloroplatinum(II): structure and cytotoxic/estrogenic activity in breast cancer cells.
Gust R; Niebler K; Schönenberger H
J Med Chem; 2005 Nov; 48(23):7132-44. PubMed ID: 16279771
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor evaluation of methyl spongoate analogs.
Jiang CS; Huang CG; Feng B; Li J; Gong JX; Kurtán T; Guo YW
Steroids; 2010 Dec; 75(13-14):1153-63. PubMed ID: 20728460
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activity of novel tetralin-6-ylpyridine and tetralin-6-ylpyrimidine derivatives.
Amin KM; El-Zahar MI; Anwar MM; Kamel MM; Mohamed MH
Acta Pol Pharm; 2009; 66(3):279-91. PubMed ID: 19645328
[TBL] [Abstract][Full Text] [Related]
11. Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer.
Akama T; Shida Y; Sugaya T; Ishida H; Gomi K; Kasai M
J Med Chem; 1996 Aug; 39(18):3461-9. PubMed ID: 8784443
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of chalcone derivatives on steroidal framework and their anticancer activities.
Saxena HO; Faridi U; Kumar JK; Luqman S; Darokar MP; Shanker K; Chanotiya CS; Gupta MM; Negi AS
Steroids; 2007 Nov; 72(13):892-900. PubMed ID: 17850837
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and qualitative structure-activity evaluations of novel hexahydropyrano[3,2-c][1,2]diazepin-3(4H)-one and tetrahydropyrano[3,2-b]pyrrol-2(1H)-one derivatives as anticancer agents.
Al-Tel TH
Eur J Med Chem; 2010 Oct; 45(10):4615-21. PubMed ID: 20691507
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and activity evaluation of phenylurea derivatives as potent antitumor agents.
Song DQ; Du NN; Wang YM; He WY; Jiang EZ; Cheng SX; Wang YX; Li YH; Wang YP; Li X; Jiang JD
Bioorg Med Chem; 2009 Jun; 17(11):3873-8. PubMed ID: 19410466
[TBL] [Abstract][Full Text] [Related]
15. Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives.
Al-Said MS; Bashandy MS; Al-Qasoumi SI; Ghorab MM
Eur J Med Chem; 2011 Jan; 46(1):137-41. PubMed ID: 21093116
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti breast cancer activity of biphenyl based chalcones.
Sharma A; Chakravarti B; Gupt MP; Siddiqui JA; Konwar R; Tripathi RP
Bioorg Med Chem; 2010 Jul; 18(13):4711-20. PubMed ID: 20605470
[TBL] [Abstract][Full Text] [Related]
17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
18. Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents.
Devegowda VN; Kim JH; Han KC; Yang EG; Choo H; Pae AN; Nam G; Choi KI
Bioorg Med Chem Lett; 2010 Mar; 20(5):1630-3. PubMed ID: 20138760
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel osthole derivatives as potential anti-breast cancer treatment.
You L; An R; Wang X; Li Y
Bioorg Med Chem Lett; 2010 Dec; 20(24):7426-8. PubMed ID: 21051232
[TBL] [Abstract][Full Text] [Related]
20. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.
Descôteaux C; Leblanc V; Bélanger G; Parent S; Asselin E; Bérubé G
Steroids; 2008 Oct; 73(11):1077-89. PubMed ID: 18572212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
